Overall presentation of products
An issue that keeps presenting with permitted indications is that [...]
Updates to Label Statements
The Permissible Indications Determination requires certain label statements, depending on [...]
Indications for Pregnancy and Foetal development
Permitted indications for Pregnancy Supplements Recent communication from the TGA [...]
Understanding the use of Population Qualifiers
Are population qualifiers mandatory? An indication must be qualified on [...]
Is your branding going to be affected by TGO 92?
TGO 92 impacts on product name presentation The new labelling [...]
GMP Clearance Guidance
TGA Clearance applications for overseas manufacturers are now required to [...]
eBS Permitted Indications
Effective March 8th 2018 Permitted indications are now available through [...]
TGA eBS Outage
The Therapeutic Goods Amendment Bill No.1. of 2017 received royal [...]
Changes to the Uniform Recall Procedure for Therapeutic Goods
The Uniform Recall Procedure for Therapeutic Goods (URPTG) is a [...]
Consultation: Business Process Improvements Supporting Complementary Medicines Assessment Pathways
The TGA is seeking comments from interested parties on a [...]